SIGNALING THROUGH THE CYTOSKELETAL PROTEIN, PAXILLIN
$256,071R01FY2000CANIH
Beth Israel Deaconess Medical Center, Boston MA
Investigators
Linked publications & trials
Abstract
DESCRIPTION: Dr. Thomas will build on her exciting preparation of pax-/- mice to investigate the role of this intriguing adapter protein in development, interactions of cells with the extracellular matrix, and as a target of transforming oncogenes such as src or abl.
View original record on NIH RePORTER →